| 000 | 01871 a2200529 4500 | ||
|---|---|---|---|
| 005 | 20250515055603.0 | ||
| 264 | 0 | _c20080108 | |
| 008 | 200801s 0 0 eng d | ||
| 022 | _a1470-269X | ||
| 024 | 7 |
_a10.1038/sj.tpj.6500433 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMa, Q | |
| 245 | 0 | 0 |
_aFetal hemoglobin in sickle cell anemia: genetic determinants of response to hydroxyurea. _h[electronic resource] |
| 260 |
_bThe pharmacogenomics journal _cDec 2007 |
||
| 300 |
_a386-94 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, N.I.H., Extramural | ||
| 650 | 0 | 4 |
_aAlcohol Oxidoreductases _xgenetics |
| 650 | 0 | 4 |
_aAnemia, Sickle Cell _xblood |
| 650 | 0 | 4 |
_aAntisickling Agents _xmetabolism |
| 650 | 0 | 4 |
_aArginase _xgenetics |
| 650 | 0 | 4 |
_aBiotransformation _xgenetics |
| 650 | 0 | 4 | _aChromosomes, Human, Pair 6 |
| 650 | 0 | 4 | _aChromosomes, Human, Pair 8 |
| 650 | 0 | 4 | _aDouble-Blind Method |
| 650 | 0 | 4 |
_aErythropoiesis _xgenetics |
| 650 | 0 | 4 |
_aFetal Hemoglobin _xmetabolism |
| 650 | 0 | 4 | _aGenotype |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHydroxyurea _xmetabolism |
| 650 | 0 | 4 | _aLinkage Disequilibrium |
| 650 | 0 | 4 |
_aNitric Oxide Synthase Type I _xgenetics |
| 650 | 0 | 4 | _aPhenotype |
| 650 | 0 | 4 | _aPolymorphism, Single Nucleotide |
| 650 | 0 | 4 | _aSeverity of Illness Index |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 | _aUnited States |
| 650 | 0 | 4 |
_aVascular Endothelial Growth Factor Receptor-1 _xgenetics |
| 700 | 1 | _aWyszynski, D F | |
| 700 | 1 | _aFarrell, J J | |
| 700 | 1 | _aKutlar, A | |
| 700 | 1 | _aFarrer, L A | |
| 700 | 1 | _aBaldwin, C T | |
| 700 | 1 | _aSteinberg, M H | |
| 773 | 0 |
_tThe pharmacogenomics journal _gvol. 7 _gno. 6 _gp. 386-94 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1038/sj.tpj.6500433 _zAvailable from publisher's website |
| 999 |
_c16858846 _d16858846 |
||